Active Pharmaceutical Ingredient (API)

Bedaquiline Fumarate

Novel Anti-Tuberculosis Agent (Diarylquinoline)

The first drug in a new class ($\text{Diarylquinolines}$) approved for $\text{MDR-TB}$ in decades. It works by inhibiting the mycobacterial $\text{ATP}$ synthase, blocking the bacterium's energy source. It is essential for newer, shorter $\text{MDR-TB}$ treatment regimens.
Technical Profile
Reference Code
BED537
CAS Number
716788-75-1
Chemical Class
N/A
Therapeutic Class
N/A
Advertisement

Verified Brands

Medicines containing Bedaquiline Fumarate as an active ingredient.

Brand Name Manufacturer Formulation MRP
We’re in the process of adding verified brands for this salt. They’ll be available here soon!.